• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性脊柱炎患者康复治疗的效果:在地中海和挪威环境中进行为期四周的康复方案的比较。

Efficacy of rehabilitation for patients with ankylosing spondylitis: comparison of a four-week rehabilitation programme in a Mediterranean and a Norwegian setting.

机构信息

Section for Climate Therapy, Department of Rheumatology, Oslo University Hospital, Rikshospitalet, PO Box 4950 Nydalen, 0424 Oslo, Norway.

出版信息

J Rehabil Med. 2011 May;43(6):534-42. doi: 10.2340/16501977-0804.

DOI:10.2340/16501977-0804
PMID:21491073
Abstract

OBJECTIVE

To investigate the sustained effect of a rehabilitation programme for patients with ankylosing spondylitis, and to compare the effect of this intervention given in a Mediterranean vs a Norwegian setting.

METHODS

A total of 107 patients with ankylosing spondylitis applying for rehabilitation were randomized to a 4-week inpatient rehabilitation programme in a Mediterranean country or in Norway. The participants were evaluated clinically before and after the rehabilitation period (week 0 and 4) and in week 16. The ASsessments in Ankylosing Spondylitis working group's Improvement Criteria (ASAS-IC), and tests of spinal mobility and physical capacity were used to measure treatment response.

RESULTS

An ASAS20 improvement was still present at week 16 in 50% of the patients treated in a Mediterranean and 23% in a Norwegian centre (p = 0.006). The tests of spinal mobility, physical capacity, and almost all patient's assessments of health status (ASAS-IC components) were still improved at week 16 after therapy in both climatic settings. While the improvements in physical capacity were comparable, the spinal mobility and ASAS-IC components improved more, and improvements were sustained longer, after rehabilitation in a Mediterranean setting.

CONCLUSION

Patients with ankylosing spondylitis benefit from a 4-week rehabilitation programme in Norway, but even more so from a similar programme in a Mediterranean setting.

摘要

目的

研究强直性脊柱炎患者康复计划的持续效果,并比较在地中海和挪威环境中进行这种干预的效果。

方法

共有 107 名强直性脊柱炎患者申请在地中海国家或挪威进行为期 4 周的住院康复计划。参与者在康复期前后(第 0 周和第 4 周)和第 16 周进行临床评估。使用强直性脊柱炎评估工作组的改善标准(ASAS-IC)以及脊柱活动度和身体能力测试来衡量治疗反应。

结果

在接受地中海治疗的患者中,有 50%在第 16 周仍有 ASAS20 改善,而在挪威中心接受治疗的患者中,这一比例为 23%(p=0.006)。在两种气候环境下,治疗后第 16 周,脊柱活动度、身体能力以及几乎所有患者的健康状况评估(ASAS-IC 组成部分)仍有改善。虽然身体能力的改善相当,但在地中海环境中进行康复治疗后,脊柱活动度和 ASAS-IC 组成部分的改善更多,并且持续时间更长。

结论

强直性脊柱炎患者在挪威接受 4 周的康复计划会受益,但在类似的地中海环境中受益更多。

相似文献

1
Efficacy of rehabilitation for patients with ankylosing spondylitis: comparison of a four-week rehabilitation programme in a Mediterranean and a Norwegian setting.强直性脊柱炎患者康复治疗的效果:在地中海和挪威环境中进行为期四周的康复方案的比较。
J Rehabil Med. 2011 May;43(6):534-42. doi: 10.2340/16501977-0804.
2
The efficacy of rehabilitation for patients with rheumatoid arthritis: comparison between a 4-week rehabilitation programme in a warm and cold climate.类风湿关节炎患者康复治疗的疗效:温暖气候与寒冷气候下4周康复计划的比较。
Scand J Rheumatol. 2009 Jan-Feb;38(1):28-37. doi: 10.1080/03009740802304549.
3
Effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria.采用ASAS反应标准评估康复治疗对活动期强直性脊柱炎的疗效。
Rheumatology (Oxford). 2007 Nov;46(11):1672-5. doi: 10.1093/rheumatology/kem247. Epub 2007 Sep 24.
4
A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial.一项为期三周的多学科住院康复计划对强直性脊柱炎患者具有积极的长期影响:随机对照试验。
J Rehabil Med. 2013 Mar;45(3):260-7. doi: 10.2340/16501977-1078.
5
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).英夫利昔单抗治疗强直性脊柱炎患者的疗效与安全性:一项随机、安慰剂对照试验(ASSERT)的结果
Arthritis Rheum. 2005 Feb;52(2):582-91. doi: 10.1002/art.20852.
6
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.阿达木单抗治疗强直性脊柱炎患者的疗效和安全性:一项多中心、随机、双盲、安慰剂对照试验的结果
Arthritis Rheum. 2006 Jul;54(7):2136-46. doi: 10.1002/art.21913.
7
Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics.强直性脊柱炎评估研究(ASAS)组反应标准在接受生物制剂治疗的强直性脊柱炎患者中的验证试验。
Arthritis Rheum. 2004 Jun 15;51(3):316-20. doi: 10.1002/art.20414.
8
Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up.肿瘤坏死因子抑制剂治疗稳定期强直性脊柱炎患者的监督训练和家庭康复:一项为期12个月随访的对照临床试验
Clin Rehabil. 2014 Jun;28(6):562-72. doi: 10.1177/0269215513512214. Epub 2013 Nov 27.
9
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial.皮下注射甲氨蝶呤治疗活动期强直性脊柱炎无效:一项为期16周的开放标签试验。
Ann Rheum Dis. 2007 Mar;66(3):419-21. doi: 10.1136/ard.2006.054098. Epub 2006 Aug 10.
10
Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis--a randomized study.自我与手法松动术可改善强直性脊柱炎男性患者的脊柱活动度——一项随机研究。
Clin Rehabil. 2009 Jul;23(7):599-608. doi: 10.1177/0269215508101748. Epub 2009 Apr 29.

引用本文的文献

1
Does the Change of Weather Influence Disease Activity in Rheumatoid Arthritis Patients: Patients' Self-Assessment via WebApp.天气变化是否会影响类风湿关节炎患者的疾病活动:患者通过网络应用程序进行自我评估。
J Clin Med. 2024 Sep 9;13(17):5336. doi: 10.3390/jcm13175336.
2
[Effect of multimodal rheumatologic complex treatment in patients with axial spondylarthritis : A systematic evaluation with standardized outcome parameters, such as the ASAS Health Index].[多模式风湿综合治疗对中轴型脊柱关节炎患者的疗效:采用标准化结局参数(如ASAS健康指数)进行的系统评价]
Z Rheumatol. 2024 Mar;83(2):153-159. doi: 10.1007/s00393-022-01241-1. Epub 2022 Jul 28.
3
Future of Rehabilitation Interventions for Rheumatic Patients in the Mediterranean Region.
地中海地区风湿病患者康复干预的未来
Mediterr J Rheumatol. 2017 Jun 27;28(2):70-74. doi: 10.31138/mjr.28.2.70. eCollection 2017 Jun.
4
[Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].[关于轴向型脊柱关节炎(包括贝赫切雷夫病和早期形式)的S3指南长版,2019年更新:德国风湿病学会(DGRh)及参与的医学科学专业学会和其他组织的循证指南]
Z Rheumatol. 2019 Dec;78(Suppl 1):3-64. doi: 10.1007/s00393-019-0670-3.
5
Comparison of Deep Tissue Massage and Therapeutic Massage for Lower Back Pain, Disease Activity, and Functional Capacity of Ankylosing Spondylitis Patients: A Randomized Clinical Pilot Study.深层组织按摩与治疗性按摩对强直性脊柱炎患者下背痛、疾病活动度和功能能力的比较:一项随机临床试验研究
Evid Based Complement Alternat Med. 2017;2017:9894128. doi: 10.1155/2017/9894128. Epub 2017 Aug 6.
6
Real-life effectiveness of spa therapy in rheumatic and musculoskeletal diseases: a retrospective study of 819 patients.温泉疗法治疗风湿和肌肉骨骼疾病的实际效果:819 例患者的回顾性研究。
Int J Biometeorol. 2017 Nov;61(11):1945-1956. doi: 10.1007/s00484-017-1384-3. Epub 2017 May 30.
7
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.非药物和非生物药物治疗的疗效与安全性:一项系统文献综述,为2016年更新的ASAS/EULAR轴性脊柱关节炎管理推荐提供依据
RMD Open. 2017 Jan 27;3(1):e000397. doi: 10.1136/rmdopen-2016-000397. eCollection 2017.
8
Readability of patient information and consent documents in rheumatological studies.风湿病学研究中患者信息及同意书的可读性
BMC Med Ethics. 2016 Jul 16;17(1):42. doi: 10.1186/s12910-016-0126-0.
9
LLLT for the management of patients with ankylosing spondylitis.低强度激光疗法用于强直性脊柱炎患者的管理。
Lasers Med Sci. 2016 Apr;31(3):459-69. doi: 10.1007/s10103-016-1874-2. Epub 2016 Jan 21.
10
Rheumatoid arthritis patients' experience of climate care.类风湿关节炎患者的气候关怀体验。
J Exerc Rehabil. 2015 Dec 31;11(6):337-44. doi: 10.12965/jer.150228. eCollection 2015 Dec.